In Italy, Cosentyx (secukinumab) is a cost-saving treatment for ankylosing spondylitis, as well as for psoriatic arthritis and moderate to severe plaque psoriasis, according to a new study. The results were published in the journal ClinicoEconomics and Outcomes Research in a paper titled, “Budget impact…
High levels of the protein chitotriosidase in the blood are associated with more disease activity in ankylosing spondylitis patients. This protein might be a useful prognostic marker. The study, “Serum chitotriosidase and neopterin levels in patients with ankylosing spondylitis,” was published in Therapeutic Advances in Musculoskeletal Disease. Chitotriosidase is…
Gender-based differences in fecal metabolites in ankylosing spondylitis patients may provide clues about differences regarding male versus female disease progression. The study with that finding, “GC-MS-based fecal metabolomics reveals gender-attributed fecal signatures in ankylosing spondylitis,” was published in Scientific Reports. There are a number of differences in how…
Get regular updates to your inbox.